{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:26:27Z","timestamp":1791012387694,"version":"4.1.0"},"reference-count":198,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1053\/j.seminoncol.2007.09.007","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T23:09:18Z","timestamp":1199315358000},"page":"476-490","source":"Crossref","is-referenced-by-count":25,"title":["The Molecular Basis of Melanomagenesis and the Metastatic Phenotype"],"prefix":"10.1053","volume":"34","author":[{"given":"A. Neil","family":"Crowson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Magro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlo","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Martin C.","family":"Mihm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2007.09.007_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0165-4608(89)90019-8","article-title":"The annals of cancer genetics","volume":"42","author":"Hecht","year":"1989","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archderm.1978.01640170032006","article-title":"Origin of familial melanomas from heritable melanocytic lesions","volume":"114","author":"Clark","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jmg.15.5.352","article-title":"Familial atypical multi-mole melanoma syndrome","volume":"15","author":"Lynch","year":"1978","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Mechanisms of disease: Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib5","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1126\/science.1439824","article-title":"Assignment of a locus for familial melanoma, MLM, to chromosome 9p13\u2013p22","volume":"258","author":"Cannon-Albright","year":"1992","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib6","first-page":"936","article-title":"Confirmation of chromosome 9p linkage to familial melanoma","volume":"53","author":"Nancarrow","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib7","first-page":"271","article-title":"Linkage analysis in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families","volume":"3","author":"Gruis","year":"1993","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib8","first-page":"489","article-title":"Linkage of cutaneous malignant melanoma\/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity","volume":"54","author":"Goldstein","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib10","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1093\/hmg\/3.12.2195","article-title":"Genetic heterogeneity in familial malignant melanoma","volume":"3","author":"MacGeoch","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib11","first-page":"2289","article-title":"Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds","volume":"11","author":"Holland","year":"1995","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib12","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1038\/sj.onc.1201470","article-title":"Analysis of the CDK2NA, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds","volume":"15","author":"Flores","year":"1997","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib13","first-page":"419","article-title":"Melanomas, from the cell cycle point of view","volume":"1","author":"Halaban","year":"1998","journal-title":"Int J Mol Med"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib14","first-page":"1649","article-title":"Chromosome 9 deletion in sporadic and familial melanomas in vivo","volume":"9","author":"Isshiki","year":"1994","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/368753a0","article-title":"Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers","volume":"268","author":"Nobori","year":"1994","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib16","first-page":"5269","article-title":"Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma","volume":"54","author":"Ohta","year":"1994","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/(SICI)1097-0215(19960315)65:6<762::AID-IJC9>3.0.CO;2-X","article-title":"Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma","volume":"65","author":"Ohta","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/gcc.2870120208","article-title":"Genetic models of melanoma tumorigenesis based on allelic losses","volume":"12","author":"Walker","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib19","first-page":"1399","article-title":"Abnormalities in the CDKN2A (p16INK4\/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis","volume":"11","author":"Luca","year":"1995","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jnci\/89.10.697","article-title":"Screening of germline mutations in the CDKN2A genes in Swedish families with hereditary utaneous melanoma","volume":"89","author":"Platz","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/120347549800200312","article-title":"Role of the cyclin-dependent kinase inhibitor CDKN2A in familial melanoma","volume":"2","author":"Hogg","year":"1998","journal-title":"J Cutan Med Surg"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199803263381305","article-title":"CDKN2A mutations in multiple primary melanomas","volume":"338","author":"Monzon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib23","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1038\/sj.onc.1201397","article-title":"Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors","volume":"165","author":"Kovar","year":"1997","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib24","first-page":"211","article-title":"Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDK\u2019s), growth suppressor genes and cyclin-dependent kinase inhibitors (CKI\u2019s)","volume":"11","author":"Grana","year":"1995","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib25","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/hmg\/6.12.2061","article-title":"Germline mutations of the CDKN2 gene in UK melanoma families","volume":"6","author":"Harland","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008390-199902000-00004","article-title":"Melanoma development in relation to non-functional p16\/INK4a protein and dysplastic nevus syndrome in Swedish melanoma kindreds","volume":"9","author":"Hashemi","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1006\/bbrc.1997.7212","article-title":"Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus","volume":"237","author":"Lee","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0046-8177(98)90221-0","article-title":"Allelic deletion at chromosome 9p21 (p16) and 17p13 (p53) in microdissected sporadic dysplastic nevus","volume":"29","author":"Park","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib29","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jnci\/89.19.1460","article-title":"Germline CDKN2A mutations in childhood melanoma (letter)","volume":"89","author":"Whiteman","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib30","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1038\/sj.onc.1202664","article-title":"Functional localization of a melanoma tumor suppressor gene to a small (< or = 2 Mb) region on 11q23","volume":"18","author":"Robertson","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ijc.2910590611","article-title":"Linkage analysis in familial melanoma kindreds to markers on chromosome 6p","volume":"59","author":"Walker","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib32","first-page":"1050","article-title":"Two-locus linkage analysis of cutaneous malignant melanoma\/dysplastic nevi","volume":"58","author":"Goldstein","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<13::AID-IJC3>3.0.CO;2-#","article-title":"Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic-based population study","volume":"78","author":"Platz","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib34","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(94)90408-1","article-title":"Incidence of familial melanoma and MLM2 gene","volume":"344","author":"Battistutta","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00000372-199812000-00075","article-title":"p16 protein expression as an important prognostic factor in primary cutaneous malignant melanoma","volume":"20","author":"Soler-Carrillo","year":"1998","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib36","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/sj.onc.1202803","article-title":"p16INK4a inactivation is not frequent in uncultured sporadic primary melanoma","volume":"18","author":"Fujimoto","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0165-4608(88)90124-0","article-title":"Chromosome rearrangements in dysplastic nevus syndrome predisposing to malignant melanoma","volume":"35","author":"Hecht","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib38","first-page":"395","article-title":"Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDNK2) gene","volume":"57","author":"Puig","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/gcc.2870120211","article-title":"Loss of heterozygosity in sporadic primary melanoma","volume":"12","author":"Healy","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib40","first-page":"589","article-title":"Allelotypes of primary cutaneous melanoma and benign melanocytic nevi","volume":"56","author":"Healy","year":"1996","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib41","first-page":"115","article-title":"CDNK2 mutations in melanoma","volume":"26","author":"Dracopoli","year":"1995","journal-title":"Cancer Surv"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib42","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1523-1747.1998.00458.x","article-title":"Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression","volume":"111","author":"Morita","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib43","first-page":"93","article-title":"Promotor methylation status of multiple genes in brain metastases of solid tumors","volume":"13","author":"Gonzalez-Gomes","year":"2004","journal-title":"Int J Mol Med"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib44","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnci\/95.10.723","article-title":"p16\/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: Possible implications for melanoma progression","volume":"95","author":"Sviderskaya","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2000.tb06637.x","article-title":"Melanin accumulation accelerates melanocyte sensescence by a mechanism involving p16INK4a\/CDK4\/pRB and E2F1","volume":"908","author":"Bandyopadhyay","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1751-1097.1999.tb07995.x","article-title":"Epidemiological support for an hypothesis for melanoma induction indication of a role for UVA radiation","volume":"70","author":"Moan","year":"1999","journal-title":"Photochem Photobiol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib47","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1128\/MCB.22.23.8135-8143.2002","article-title":"Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts","volume":"22","author":"Huot","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00000372-199502000-00002","article-title":"bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi","volume":"17","author":"Cerroni","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib49","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archderm.1995.01690200051010","article-title":"Bcl-2 expression in melanocytic nevi","volume":"131","author":"Morales-Ducret","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib50","first-page":"150","article-title":"Bcl-2 protein expression in melanocytic neoplasms of the skin","volume":"8","author":"Ramsey","year":"1995","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0560.1994.tb00278.x","article-title":"Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi","volume":"21","author":"Saenz-Santamaria","year":"1994","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0046-8177(96)90108-2","article-title":"Differential expression of bcl-2 oncogene in human basal cell carcinoma","volume":"27","author":"Crowson","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib53","first-page":"56A","article-title":"Expression of p21WAF1\/CIP1 in aggressive- versus non-aggressive-growth basal cell carcinoma: A comparative study","volume":"79","author":"Crowson","year":"1999","journal-title":"Lab Invest"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/1523-1747.ep12323809","article-title":"Microsatellite instability and loss of heterozygosity in melanoma","volume":"105","author":"Peris","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib55","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0002-9440(10)63536-5","article-title":"Classifying melanocytic tumors based on DNA copy number changes","volume":"163","author":"Bastian","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib56","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1038\/sj.onc.1207228","article-title":"CD95\/Fas signaling in human melanoma cells: Conditional expression of CD95L\/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants","volume":"22","author":"Eberle","year":"2003","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/mccm.6.3.135.140","article-title":"Effect of endogenous interleukin-6 on Fas (APO-1\/CD95) receptor expression in advanced melanoma patients","volume":"6","author":"Mouawad","year":"2000","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00008390-200304000-00007","article-title":"Interferon-gamma and anti-Fas antibody-induced apoptosis in human melanoma cell lines and its relationship to bcl-2 cleavage","volume":"13","author":"Kamei","year":"2003","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib59","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1523-1747.2000.00164.x","article-title":"Inhibition of growth of melanoma cells by CD95 (Fas\/APO-1) gene transfer in vivo","volume":"115","author":"Aragane","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00008390-200010000-00008","article-title":"Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma","volume":"10","author":"Mouawad","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00008390-199906000-00008","article-title":"Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10","volume":"9","author":"Ekmekcioglu","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2133.2000.03655.x","article-title":"A comparative study of Fas and Fas-ligand expression during melanoma progression","volume":"143","author":"Soubrane","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib63","first-page":"993","article-title":"Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: In vitro studies with fresh human tumor samples","volume":"79","author":"Faraoni","year":"1999","journal-title":"Lab Invest"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<559::AID-CNCR3>3.0.CO;2-4","article-title":"Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis","volume":"86","author":"Jong","year":"1999","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/gcc.10135","article-title":"Human chromosome 5 carries a putative telomerase repressor gene","volume":"36","author":"Kugoh","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib66","first-page":"245","article-title":"Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer","volume":"11","author":"Novakovic","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00008390-200304000-00005","article-title":"Increased expression of apoptoic markes in melanoma","volume":"13","author":"Slater","year":"2003","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib68","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0002-9440(10)65011-0","article-title":"Telomerase activity in melanocytic lesions: A potential marker of tumor biology","volume":"156","author":"Rudolph","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0906-6705.2004.00114.x","article-title":"Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases","volume":"13","author":"Becker","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib70","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1083\/jcb.145.2.203","article-title":"Uncapping and deregulation of telomeres lead to detrimental consequences in yeast","volume":"145","author":"Smith","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib71","first-page":"210","article-title":"Ancient melanocytic nevus","volume":"15","author":"Kerl","year":"1998","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.onc.1206143","article-title":"Identification of a <\/=600-kb region on human chromosome 1q42.3 inducing cellular senescence","volume":"22","author":"Yawata","year":"2003","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib73","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1158\/0008-5472.CAN-03-1339","article-title":"Human telomerase reverse transcriptase-transduced human cytotoxic T-cells suppress the growth of human melanoma in immunodeficient mice","volume":"64","author":"Verra","year":"2004","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib74","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib75","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinctive subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib76","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00008390-200010000-00001","article-title":"Protein tyrosine kinases in malignant melanoma","volume":"10","author":"Easty","year":"2000","journal-title":"Melanoma Res"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2007.09.007_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.5-suppl_1-3","article-title":"VEGF signalling in tumor angiogenesis","volume":"5","author":"McMahon","year":"2000","journal-title":"Oncologist"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib78","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1523-1747.2002.01854.x","article-title":"Regulation of Fas-mediated apoptosis by N-ras in melanomas","volume":"119","author":"Urquhart","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib79","first-page":"349","article-title":"Induction of different morphological features of malignant melanoma and pigmented lesions after transformation of murine melanocytes with bFGF-cDNA and H-ras, myc, neu and E1a oncogenes","volume":"138","author":"Ramon y Cajal","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib80","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000011967","article-title":"Prognostic classification of malignant melanoma by combining clinical, histological, and immunohistochemical parameters","volume":"56","author":"Otto","year":"1999","journal-title":"Oncology"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1054\/bjps.1998.3024","article-title":"Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma","volume":"52","author":"Grover","year":"1999","journal-title":"Br J Plast Surg"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.SAP.0000032308.89737.EA","article-title":"Use of oncogene expression as an independent prognostic marker for primary melanoma","volume":"50","author":"Grover","year":"2003","journal-title":"Ann Plast Surg"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib83","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1300","article-title":"Apoptosis and melanoma: Molecular mechansisms","volume":"199","author":"Hussein","year":"2003","journal-title":"J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib84","doi-asserted-by":"crossref","first-page":"35693","DOI":"10.1074\/jbc.M304597200","article-title":"Inhibition of c-Myc oncoprotein limits the growth of human melanoma cells by inducing cellular crisis","volume":"278","author":"Biroccio","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib85","first-page":"4594","article-title":"Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models","volume":"9","author":"Pastorino","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008390-200402000-00002","article-title":"C-Myc is able to sensitize human melanoma cells to diverse apoptotic triggers","volume":"14","author":"Peltenburg","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib87","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1081\/CNV-120005904","article-title":"Expression of c-myc and bcl-2 in primary and advanced cutaneous melanoma","volume":"20","author":"Utikal","year":"2002","journal-title":"Cancer Invest"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib88","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00000372-200302000-00002","article-title":"Gene expression profiling of melanocytic tumors","volume":"25","author":"Seykora","year":"2003","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib89","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1359641","article-title":"Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors","volume":"258","author":"Kallioniemi","year":"1992","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib90","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/2524","article-title":"High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays","volume":"20","author":"Pinkel","year":"1998","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib91","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng754","article-title":"Assembly of microarrays for genome-wide measurement of DNA copy number","volume":"29","author":"Snijders","year":"2001","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib92","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/75985","article-title":"Quantitative mapping of amplicon structure by array CGH identified CYP24 as a candidate oncogene","volume":"25","author":"Albertson","year":"2000","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib93","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng1307","article-title":"A tiling resolution DNA microarray with complete coverage of the human genome","volume":"36","author":"Ishkanian","year":"2004","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib94","first-page":"2170","article-title":"Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization","volume":"58","author":"Bastian","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib95","first-page":"1968","article-title":"Gene amplifications characterize acral melanomas and permit the detection of occult tumor cells in the surrounding skin","volume":"60","author":"Bastian","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib96","first-page":"3200","article-title":"Cyclin D1 is a candidate oncogene in cutaneous melanoma","volume":"62","author":"Sauter","year":"2002","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib97","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1747.1999.00787.x","article-title":"Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma","volume":"113","author":"Bastian","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib98","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0560.1990.tb00110.x","article-title":"Evaluation of DNA ploidy in dysplastic and Spitz nevi by flow cytometry","volume":"17","author":"Winokur","year":"1990","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib99","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00000478-200205000-00012","article-title":"Persistent (recurrent) Spitz nevi: A histopathologic, immunohistochemical, and molecular pathologic study of 22 cases","volume":"26","author":"Harvell","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib100","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0002-9440(10)63736-4","article-title":"Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway","volume":"164","author":"Maldonado","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib101","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2353\/ajpath.2006.050711","article-title":"Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY 43-9006)","volume":"169","author":"Murphy","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib102","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.seminoncol.2006.04.002","article-title":"Role of Raf kinase in cancer: Therapeutic potential of targeting the Raf\/MEK\/ERK signal transduction pathway","volume":"33","author":"Gollob","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib103","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1523-1747.ep12312431","article-title":"MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas","volume":"105","author":"Ramsay","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib104","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00000372-199802000-00003","article-title":"Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors","volume":"20","author":"Sparrow","year":"1998","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib105","series-title":"The Melanocytic Proliferations: A Comprehensive Textbook of Pigmented Lesions","author":"Crowson","year":"2001"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib106","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/0190-9622(95)91332-7","article-title":"Expression of proliferating cell nuclear antigen in Spitz nevus","volume":"32","author":"Penneys","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00008390-199408000-00002","article-title":"Proliferating cell nuclear antigen (PCNA) and recurrence in patients with cutaneous melanoma","volume":"4","author":"Vecchiato","year":"1994","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib108","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0959-8049(95)00562-5","article-title":"Correlation of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma","volume":"32A","author":"Karlsson","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib109","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1096-9098(199903)70:3<150::AID-JSO2>3.0.CO;2-Z","article-title":"Prognostic evaluation of cutaneous malignant melanoma: A clinicopathological and immunohistochemical study","volume":"70","author":"Niezabitowski","year":"1999","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib110","first-page":"483","article-title":"Tumor characteristics involved in the metastatic behaviour as an improvement in primary cutaneous melanoma prognostics","volume":"17","author":"Goldmann","year":"1998","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib111","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0560.1995.tb00746.x","article-title":"Cell proliferation markers in predicting metastases in malignant melanoma","volume":"22","author":"Reddy","year":"1995","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib112","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/bjc.1998.318","article-title":"Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma","volume":"77","author":"Karjalainen","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib113","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/modpathol.3800517","article-title":"Prognosticators of melanoma and the sentinel lymph node","volume":"19","author":"Crowson","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib114","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D","article-title":"A new American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"88","author":"Balch","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-0749.1997.tb00479.x","article-title":"Prediction of outcome for patients with cutaneous melanoma","volume":"10","author":"Cochran","year":"1997","journal-title":"Pigment Cell Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib116","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)65023-7","article-title":"E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-associated adhesion receptors","volume":"156","author":"Hsu","year":"2000","journal-title":"Am J Pathol"},{"issue":"suppl","key":"10.1053\/j.seminoncol.2007.09.007_bib117","doi-asserted-by":"crossref","first-page":"196S","DOI":"10.1038\/jid.1993.76","article-title":"Role of growth factors and their receptors in the development and progression of melanoma","volume":"100","author":"Shih","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib118","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00008390-199205000-00003","article-title":"Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapy","volume":"2","author":"Kato","year":"1992","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1440-0960.1999.00310.x","article-title":"Differential expression of epidermal growth factor receptor in melanocytic tumours demonstrated by immunohistochemistry and mRNA in situ hybridization","volume":"40","author":"Sparrow","year":"1999","journal-title":"Australas J Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<160::AID-IJC12>3.0.CO;2-R","article-title":"Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions","volume":"84","author":"Moretti","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib121","first-page":"547","article-title":"Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells","volume":"59","author":"Rodeck","year":"1999","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib122","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/sj.onc.1201358","article-title":"Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells","volume":"15","author":"Xie","year":"1997","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib123","first-page":"97","article-title":"Expression of transforming growth factor-beta 2 in malignant melanoma correlates with depth of tumor invasion","volume":"145","author":"Reed","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib124","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1242\/jcs.105.2.501","article-title":"Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-stimulated mouse melanoma cell motility and invasive behaviour on type I collagen","volume":"106","author":"Faasen","year":"1993","journal-title":"J Cell Sci"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib125","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0046-8177(99)90202-2","article-title":"Progression-related expression of \u03b23 integrin in melanomas and nevi","volume":"33","author":"Van Belle","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib126","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<375::AID-CNCR15>3.0.CO;2-1","article-title":"Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma","volume":"85","author":"Hieken","year":"1999","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib127","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/jsre.1996.0242","article-title":"Beta3 integrin expression in melanoma predicts subsequent metastasis","volume":"63","author":"Hieken","year":"1996","journal-title":"J Surg Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib128","first-page":"2321","article-title":"Beta 1 integrin expression: A marker of lymphatic metastases in cutaneous malignant melanoma","volume":"16","author":"Hieken","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00008390-199708000-00006","article-title":"In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expression","volume":"7","author":"Moretti","year":"1997","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib130","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/(SICI)1097-0215(19961127)68:5<650::AID-IJC16>3.0.CO;2-5","article-title":"Up-regulated expression of the beta3 integrin and the 92kDa gelatinase in human HT-144 melanoma cell tumors grown in nude mice","volume":"68","author":"Gouon","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib131","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1074\/jbc.275.11.8051","article-title":"New functions for non-collagenous domains of human collagen type IV","volume":"275","author":"Peticlerc","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib132","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1074\/jbc.275.7.4796","article-title":"Regulation of tumor cell chemtoaxis by type IV collagen is mediated by a Ca(2+)-dependent mechanism requiring CD47 and the integrin alpha(v)beta(3)","volume":"275","author":"Shahan","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib133","doi-asserted-by":"crossref","first-page":"35264","DOI":"10.1074\/jbc.M003969200","article-title":"The inetgrins alpha 3 beta 1 and alpha 6 beta 1 physically and functionally associate with CD36 in human melanoma cells","volume":"275","author":"Thorne","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib134","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1006329410433","article-title":"The biology of melanoma brain metastasis","volume":"18","author":"Fidler","year":"1999","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/1097-0215(20000701)87:1<12::AID-IJC3>3.0.CO;2-A","article-title":"Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo","volume":"87","author":"Hofmann","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib136","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s002620000124","article-title":"Alpha(v)beta3 expression on blood vessels and melanoma cells in primary lesions: Differential association with tumor progression and clinical prognosis","volume":"49","author":"Kageshita","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib137","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1023\/A:1006317125454","article-title":"Molecular role(s) for integrins in human melanoma invasion","volume":"18","author":"Seftor","year":"1999","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib138","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1073\/pnas.170290997","article-title":"Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1","volume":"97","author":"Henriet","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib139","first-page":"2363","article-title":"Expression of integrin alpha5beta1 and MMPs associated with epithelioid cytomorphology and malignancy of uveal melanoma","volume":"41","author":"Beliveau","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008390-200006000-00006","article-title":"Prognostic value of beta1 integrin expression in metastatic melanoma","volume":"10","author":"Vihinen","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib141","first-page":"6660","article-title":"Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44","volume":"51","author":"Birch","year":"1991","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib142","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0046-8177(96)90339-1","article-title":"CD44 expression in benign and malignant nevomelanocytic lesions","volume":"27","author":"Leigh","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib143","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0560.1998.tb01719.x","article-title":"CD44 and variants in melanocytic skin neoplasms","volume":"25","author":"Schaider","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib144","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2133.1998.02255.x","article-title":"Moesin and CD44 expression in cutaneous melanocytic tumours","volume":"138","author":"Ichikawa","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0046-8177(99)90014-X","article-title":"Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas","volume":"30","author":"Massi","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib146","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000015439","article-title":"Assignment of the human melanoma cell adhesion molecule gene (MCAM) to chromosome 11 band q23.3 by radiation hybrid mapping","volume":"87","author":"Kuske","year":"1999","journal-title":"Cytogenet Cell Genet"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib147","first-page":"3835","article-title":"Melanoma cell-cell interactions are mediated through heterophile Mel-CAM\/ligand interaction","volume":"57","author":"Shih","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib148","doi-asserted-by":"crossref","first-page":"34672","DOI":"10.1074\/jbc.M003812200","article-title":"Identification of the elements regulating the expression of the cell adhesion molecule MCAM\/MUC18","volume":"275","author":"Mintz-Weber","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib149","first-page":"2295","article-title":"Expression of MCAM\/MUC 18 by human melanoma cells leads to increased tumor growth and metastasis","volume":"57","author":"Xie","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P","article-title":"The role of CD146 (Mel-CAM) in biology and pathology","volume":"189","author":"Shih","year":"1999","journal-title":"J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib151","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1007128101751","article-title":"Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family","volume":"212","author":"Jean","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib152","doi-asserted-by":"crossref","first-page":"24884","DOI":"10.1074\/jbc.273.38.24884","article-title":"CREB and its associated proteins act as survival factors for human melanoma cells","volume":"273","author":"Jean","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib153","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.onc.1201566","article-title":"ATF2 confers radiation resistance to human melanoma cells","volume":"16","author":"Ronai","year":"1998","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib154","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1034\/j.1600-0560.2000.027001024.x","article-title":"Expression of desmoglein I and plakoglobin in skin carcinomas","volume":"27","author":"Tada","year":"2000","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00000372-199912000-00006","article-title":"Actin-rich desmoplastic malignant melanoma","volume":"21","author":"Riccioni","year":"1999","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib156","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1126\/science.1549777","article-title":"Actin-binding protein requirement for cortical stability and efficient locomotion","volume":"255","author":"Cunningham","year":"1992","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib157","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00000372-199104000-00006","article-title":"Expression of cytoskeletal components in melanocytic skin lesions","volume":"13","author":"Puches","year":"1991","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib158","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/1523-1747.ep12496020","article-title":"Alpha-smooth muscle actin expression in tumor and stromal cells of benign and malignant human pigment tumors","volume":"98","author":"Tsukamoto","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib159","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ijc.2910560514","article-title":"A variant actin (beta m) reduces metastases of mouse B16 melanoma","volume":"56","author":"Shimokawa-Kuroki","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib160","first-page":"63","article-title":"Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility","volume":"148","author":"Chu","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib161","first-page":"938","article-title":"In situ distribution of integrin alpha 2 beta 1 and alpha-actinin in melanocytic proliferations","volume":"9","author":"Duncan","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib162","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0046-8177(94)90305-0","article-title":"Actin-binding protein expression in benign and malignant melanocytic proliferations","volume":"25","author":"Bouffard","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib163","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1346-8138.1992.tb03795.x","article-title":"Actin organization and cell migration of melanoma cells relate to differential expression of integrins and actin-associated proteins","volume":"19","author":"Byers","year":"1992","journal-title":"J Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib164","first-page":"26","article-title":"Interrelation of motility, cytoskeletal organization and gap junctional communication with invasiveness of melanocytic cells in vitro","volume":"17","author":"Helige","year":"1997","journal-title":"Invasion Metastasis"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00008390-199808000-00003","article-title":"Positive attachment between cytoskeletal changes, melanoma cell attachment and invasion in vitro","volume":"8","author":"Dewhurst","year":"1998","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib166","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s004410051129","article-title":"Cell shape changes and cytoskelton reorganization during transmigration of human melanoma cells","volume":"293","author":"Voura","year":"1998","journal-title":"Cell Tissue Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib167","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1074\/jbc.275.1.271","article-title":"Physical and functional interaction of filamin (actin-binding protein 280) and tumor necrosis factor receptor-associated factor 2","volume":"2745","author":"Leonardi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib168","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9896(199809)186:1<51::AID-PATH131>3.0.CO;2-P","article-title":"Prognostic value of MMP-2 immunoreactive protein (72kD type IV collagenase) in primary skin melanoma","volume":"186","author":"Vaisanen","year":"1998","journal-title":"J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib169","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.patbio.2004.02.002","article-title":"[Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression]","volume":"52","author":"Ntayi","year":"2004","journal-title":"Pathol Biol (Paris)"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.bjc.6690417","article-title":"Expression of collagenases-1 and \u22123 and their inhibitors TIMP-1 and \u22123 correlates with the level of invasion in malignant melanomas","volume":"80","author":"Airola","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib171","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.0022-202X.2003.22114.x","article-title":"Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth","volume":"122","author":"Iida","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib172","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/B:CLIN.0000006824.41376.b0","article-title":"Melanoma invasion in reconstructed human skin is influenced by skin cells\u2014Investigation of the role of proteolytic enzymes","volume":"20","author":"Eves","year":"2003","journal-title":"Clin Exp Metastasis"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib173","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00403-003-0429-0","article-title":"Influence of cultured dermal fibroblasts on human melanoma cell proliferation, matrix metalloproteinase-2 (MMP-2) expression and invasion in vitro","volume":"295","author":"Ntayi","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-4827(03)00336-7","article-title":"Transforming growth factor-beta 1 inhibits tumor growth in a mouse model by down-regulating the plasminogen activation system","volume":"291","author":"Ramont","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib175","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/1523-1747.ep12665371","article-title":"Expression of cathepsin D in primary and metastatic melanoma and dysplastic nevi","volume":"104","author":"Podhajcer","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib176","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1034\/j.1600-0749.2003.00058.x","article-title":"The \u2018Abtropfung phenonmenon\u2019 revisited: Dermal nevus cells from congenital nevi cannot activiate matrix metalloproteinase 2 (MMP-2)","volume":"16","author":"Gontier","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib177","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1006573417179","article-title":"The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells","volume":"17","author":"Wylie","year":"1999","journal-title":"Clin Exp Metastasis"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib178","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1699-0463.1999.tb01533.x","article-title":"Tissue inhibitors of metalloproteinase (TIMP) in invasion and proliferation","volume":"107","author":"Henriet","year":"1999","journal-title":"APMIS"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib179","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.bjc.6690217","article-title":"Inhibition of invasion and induction of cell death of cancer cell lines by overexpression of TIMP-3","volume":"79","author":"Baker","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib180","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/sj.onc.1206292","article-title":"Tissue inhibitor of metalloproteinase-3 induces apoptosis in melanoma cells by stabilization of death receptors","volume":"22","author":"Ahonene","year":"2003","journal-title":"Oncogene"},{"issue":"suppl 66","key":"10.1053\/j.seminoncol.2007.09.007_bib181","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.0366-077X.2003.05637.x","article-title":"Treatment of lentigo maligna with topical imiquimod","volume":"149","author":"Naylor","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib182","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.0007-0963.2004.05898.x","article-title":"In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases","volume":"150","author":"Hesling","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib183","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0190-9622(96)90728-8","article-title":"Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma","volume":"35","author":"Iwamoto","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib184","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jcb.10649","article-title":"p75 neurotrophin receptor functions as a survival receptor in brain-metastastic melanoma cells","volume":"91","author":"Marchetti","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib185","first-page":"329","article-title":"Differential expression of basic fibroblastic growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization","volume":"144","author":"Reed","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib186","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/sj.onc.1203066","article-title":"Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes","volume":"18","author":"Nesbit","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib187","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9440(10)64719-0","article-title":"Human melanoma progression in skin reconstructs: biological significance of bFGF","volume":"156","author":"Meir","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib188","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1053\/hupa.2002.124014","article-title":"Lentigo maligna and superficial spreading melanoma are different in their in situ phase: An immunohistochemical study","volume":"33","author":"Auslender","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib189","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/jir.1995.15.81","article-title":"Heterogeneity of cytokine and growth factor gene expression in human melanoma cells with metastatic potentials","volume":"15","author":"Singh","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib190","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/(SICI)1097-0215(19980610)76:6<836::AID-IJC12>3.0.CO;2-0","article-title":"VEGF, bFGF and EGF in the angiogenesis of human melanoma xenografts","volume":"76","author":"Danielsen","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib191","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0959-8049(02)00150-8","article-title":"Neovascularization, expression of fibroblast growth factor-2 and mast cells with tryptase activity increase simultaneously with pathological expression in human malignant melanoma","volume":"39","author":"Ribatti","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib192","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1600-0560.1996.tb01441.x","article-title":"Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression","volume":"23","author":"Reed","year":"1996","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib193","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0560.1996.tb01284.x","article-title":"Expression of basic fibroblast growth factor in desmoplastic melanoma","volume":"23","author":"Al-Alousi","year":"1996","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib194","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.2910500423","article-title":"The desmoplastic response: Induction of collagen synthesis by melanoma cells in vitro","volume":"50","author":"Fearns","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib195","first-page":"137","article-title":"Ultrastructural observations concerning laminin in B16 melanoma","volume":"30","author":"Lugassy","year":"1998","journal-title":"J Submicrosc Cytol Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib196","first-page":"231","article-title":"Angio-tumoral laminin in murine tumors derived from human melanoma cell lines","volume":"30","author":"Lugassy","year":"1998","journal-title":"J Submicrosc Cytol Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib197","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0560.1999.tb01806.x","article-title":"Ultrastructural and immunohistochemical studies of the periendothelial matrix in human melanoma: Evidence for an amorphous matrix containing laminin","volume":"26","author":"Lugassy","year":"1999","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2007.09.007_bib198","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-0560.1999.tb01834.x","article-title":"Tumor microvessels in melanoma express the beta-2 chain of laminin","volume":"26","author":"Lugassy","year":"1999","journal-title":"J Cutan Pathol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775407001777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775407001777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:08:14Z","timestamp":1630447694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775407001777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":198,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0093775407001777"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2007.09.007","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}